Clinical Trial Update: FDG PET/CT in Lung Cancer Staging [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports the completed status of a study evaluating FDG PET/CT for staging non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Non-Small Cell Lung Cancer (NSCLC) | NA | Status: COMPLETED